arrow
K

Katrina Hueniken

department of radiation oncology
H指数:16
被引数:758

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T

桥接疗法在复发/难治性大B细胞淋巴瘤患者接受第三代CAR T治疗中的效果

2026-03-030
PRE
Multi-institutional Normal Tissue Complication Probability (NTCP) Prediction Model for Mandibular Osteoradionecrosis: Results from the PREDMORN Study

多机构下颌骨放射性骨坏死正常组织并发症概率(NTCP)预测模型:PREDMORN研究的结果

2026-01-080
OAAI
Buccal fat applied to transoral robotic lateral oropharyngectomy defects to lessen radical tonsillectomy pain (BOLT): a single-centre, phase II, parallel, randomised control trial study protocol

颊脂肪垫应用于经口机器人侧咽切除术缺损以减轻根治性扁桃体切除术疼痛(BOLT):一项单中心、二期、平行、随机对照试验研究方案

2025-12-120
OA
Immunogenicity and safety of third, fourth and subsequent COVID-19 vaccine doses in recipients of hematopoietic cell transplantation and cellular therapy

造血细胞移植和细胞治疗受者接种第三、第四及后续COVID-19疫苗剂量的免疫原性和安全性

2025-11-080
PRE
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases

一项回顾性分析,探讨治疗前中性粒细胞与淋巴细胞比值与晚期非小细胞肺癌伴肝转移患者免疫检查点抑制剂疗效的关联。

2025-10-220
OA
Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms

对KRAS-G12C抑制剂AZD4625在KRASG12C NSCLC患者来源的异种移植模型中的反应进行建模,揭示了原发性耐药机制方面的见解。

2025-10-110
OA
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies

多剂量SARS-CoV-2疫苗接种在血液恶性肿瘤患者中的增量免疫原性

2025-07-300
OAAI
Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus status

不同系统性炎症生物标志物与人类乳头瘤病毒状态相关的头颈部鳞状细胞癌患者生存结局的差异性预后关联

2025-06-170
PRE
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials

加拿大癌症试验组中早期纵向毒性轨迹的机器学习模型预测西妥昔单抗浓度和转移性结直肠癌生存率/AGITG CO.17/20试验

2025-04-010
PRE
Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma

8个吸烟指标在头颈部鳞状细胞癌生存建模中的性能

2025-02-200
PRE
Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutations

TP53共突变在具有罕见可治疗驱动基因突变非小细胞肺癌患者中的预后和预测效果

2025-02-010
PRE
Deep learning-based clustering for endotyping and post-arthroplasty response classification using knee osteoarthritis multiomic data

基于深度学习的聚类方法用于 knee osteoarthritis 多组学数据的表型分析和术后关节置换反应分类

2025-02-012
OAAI
TLR4 downregulation protects against cisplatin-induced ototoxicity in adult and pediatric patients with cancer
2025-02-010
PRE
Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations
2024-12-230
OAAI